BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29483385)

  • 21. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and three-year noninvasive follow-up in 18 patients.
    Guo H; Wang J; Chen J; Shan J; Lee JD; Ueda T
    Can J Cardiol; 2004 Jun; 20(8):779-82. PubMed ID: 15229758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy.
    Sedehi D; Finocchiaro G; Tibayan Y; Chi J; Pavlovic A; Kim YM; Tibayan FA; Reitz BA; Robbins RC; Woo J; Ha R; Lee DP; Ashley EA
    J Cardiol; 2015 Jul; 66(1):57-62. PubMed ID: 25238885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.
    Seggewiss H; Gleichmann U; Faber L; Fassbender D; Schmidt HK; Strick S
    J Am Coll Cardiol; 1998 Feb; 31(2):252-8. PubMed ID: 9462563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful percutaneous septal alcohol ablation after surgical myectomy.
    Kulić M; Spuzić M; Tahirović E; Sehović S; Mujacić V; Zorman D; Velebit V
    Bosn J Basic Med Sci; 2010 Aug; 10(3):218-22. PubMed ID: 20846128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Percutaneous transluminal septal myocardial ablation: early results and long-term follow-up].
    Tekieli Ł; Pieniazek P; Podolec P; Tomkiewicz-Pajak L; Płazak W; Musiałek P; Leśniak-Sobelga A; Przewłocki T; Biernacka B; Zmudka K; Tracz W
    Przegl Lek; 2006; 63(8):628-32. PubMed ID: 17441371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of left ventricular myocardial perfusion and function using gated SPECT in patients with hypertrophic obstruction cardiomyopathy following percutaneous transluminal septal myocardial ablation.
    Zhang L; Liu R; Qiao SB; Sun XX; He ZX; Tian YQ
    Nucl Med Commun; 2014 Jul; 35(7):762-6. PubMed ID: 24681766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results in 66 patients with reference to myocardial contrast echocardiography].
    Faber L; Seggewiss H; Fassbender D; Bogunovic N; Strick S; Schmidt HK; Gleichmann U
    Z Kardiol; 1998 Mar; 87(3):191-201. PubMed ID: 9586154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term clinical and echocardiographic outcomes of extensive septal myectomy for hypertrophic obstructive cardiomyopathy in Chinese patients.
    Yao L; Li L; Lu XJ; Miao YL; Kang XN; Duan FJ
    Cardiovasc Ultrasound; 2016 May; 14(1):18. PubMed ID: 27189485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Septal Reduction on Left Atrial Size and Diastole in Hypertrophic Cardiomyopathy.
    Finocchiaro G; Haddad F; Kobayashi Y; Lee D; Pavlovic A; Schnittger I; Sinagra G; Magavern E; Myers J; Froelicher V; Knowles JW; Ashley E
    Echocardiography; 2016 May; 33(5):686-94. PubMed ID: 26926154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic resonance imaging of microvascular obstruction in hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation.
    Amano Y; Kitamura M; Yamada F; Aita K; Takayama M; Tachi M; Kumita S
    Acta Radiol; 2015 Nov; 56(11):1323-8. PubMed ID: 25414371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.
    Seggewiss H; Faber L; Gleichmann U
    Thorac Cardiovasc Surg; 1999 Apr; 47(2):94-100. PubMed ID: 10363608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
    Alam M; Dokainish H; Lakkis N
    J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Latent outflow tract obstruction in hypertrophic cardiomyopathy: Clinical characteristics and outcomes of septal myectomy.
    Cui H; Schaff HV; Nishimura RA; Dearani JA; Geske JB; Ommen SR
    J Thorac Cardiovasc Surg; 2022 Dec; 164(6):1863-1869.e1. PubMed ID: 33468328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contemporary Septal Reduction Therapy in Drug-Refractory Hypertrophic Obstructive Cardiomyopathy.
    Maekawa Y; Akita K; Takanashi S
    Circ J; 2018 Jul; 82(8):1977-1984. PubMed ID: 29910224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progressive decrease of outflow gradient and septum thickness after percutaneous alcoholization of the interventricular septum in hypertrophic obstructive cardiomyopathy.
    Airoldi F; Di Mario C; Catanoso A; Dharmadhikari A; Tzifos V; Anzuini A; Carlino M; Briguori C; Montorfano M; Vaghetti M; Tolaro S; Colombo A
    Ital Heart J; 2000 Mar; 1(3):200-6. PubMed ID: 10806987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16-Year Australian Single Centre Experience.
    Nogic J; Koh Y; Bak M; Gooley RP; Meredith IT; McCormick LM
    Heart Lung Circ; 2018 Dec; 27(12):1446-1453. PubMed ID: 29129561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of septal myectomy in patients with hypertrophic obstructive cardiomyopathy.
    Havndrup O; Pettersson G; Kjeldsen K; Bundgaard H
    Scand Cardiovasc J; 2000 Dec; 34(6):564-9. PubMed ID: 11214008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of early clinical effects of ablation with surgery treatment in patients with hypertrophic cardiomyopathy].
    Ruan YP; Liu XW; Zhang Y; Han JC; Lai YQ; Lü J; He YH
    Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(45):3553-3557. PubMed ID: 29275594
    [No Abstract]   [Full Text] [Related]  

  • 40. A Narrative Review of Emerging Therapies for Hypertrophic Obstructive Cardiomyopathy.
    da Silva Menezes Junior A; de Oliveira ALV; Maia TA; Botelho SM
    Curr Cardiol Rev; 2023; 19(4):e240323214927. PubMed ID: 36999417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.